Alkanna cappadocica
Alkanna cappadocica · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Alkanna cappadocica is a botanical species that has garnered significant scientific interest due to its unique phytochemical profile. Researchers primarily focus on the plant's roots, specifically utilizing a dichloromethane/methanol (1:1) extract for detailed analysis. This specific preparation is rich in bioactive naphthoquinones, including key compounds such as alkannin, 11-deoxyalkannin, and 11-O-acetylalkannin. These chemical constituents are of particular importance because they exhibit potent anticancer activities in various experimental models. Consequently, studying this plant offers promising pathways for the development of new therapeutic agents in oncology.
- Synonyms
- Alkanna Reeseana
- Common names
- Not available
- Family
- Boraginaceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Synonyms
Alkanna cappadocica is a botanical species that has undergone taxonomic revisions within its scientific classification. In various botanical records, this plant is also identified by the synonym Alkanna reeseana. Such nomenclatural shifts are common as researchers refine the understanding of plant lineages and genetic traits. Recognizing these synonymous names is essential for scientists to ensure consistency across different herbarium collections. Consequently, both terms can be used interchangeably when documenting the presence of this particular species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Alkanna cappadocica is a distinct biological entity belonging to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further occupies a specific position within the order Boraginales. As a member of the Boraginaceae family, it shares characteristics with many other flowering plants. Ultimately, this plant is defined by its placement within the genus Alkanna.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Boraginales |
| Family | Boraginaceae |
| Genus | Alkanna |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Alkanna cappadocica is a distinct botanical species with a specific geographical footprint. It is primarily distributed throughout the Asia-Temperate region, finding its niche in diverse ecological settings. Within this broad range, the plant is notably prevalent in Western Asia. Türkiye serves as a key area where this species can be frequently identified in the wild. Understanding these specific locations helps researchers better grasp the plant's natural habitat and environmental needs.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Alkanna cappadocica has emerged as a significant subject of study in the ongoing search for novel anticancer agents. Research focused on the plant's roots led to the isolation of several naphthoquinones, including both known and newly characterized compounds. During bioassays conducted against twelve different human cancer cell lines, these substances demonstrated notable cytotoxic properties. Specifically, the compound 5-O-methyl-11-O-acetylalkannin showed remarkable potency, even surpassing positive controls like doxorubicin in several instances. These findings highlight the therapeutic potential of the mono-O-methylated alkannin derivatives in fighting various forms of cancer.
Compounds
Alkanna cappadocica serves as a significant botanical source for several bioactive naphthoquinones. Research involving the fractionation of its roots has successfully identified various chemical constituents within the plant. Specifically, the species is known to contain the compound 11-deoxyalkannin. Furthermore, the plant contains 11-O-acetylalkannin, which contributes to its complex chemical profile. Finally, the presence of alkannin has also been confirmed, highlighting the diverse medicinal potential of this species.
Conditions
Alkanna cappadocica contains naphthoquinone compounds that exhibit significant cytotoxic activity against various human cancer cell lines. Specifically, the plant's derivatives demonstrate the ability to treat AU565 cells through potent inhibitory effects. Research also confirms that these extracts are effective in treating DU 145 and HT-29 cancer cell lines. Furthermore, the medicinal properties of Alkanna cappadocica extend to the treatment of HeLa cells. Finally, the plant shows therapeutic potential in treating Hep 3B cells, showcasing its diverse anticancer capabilities.
Preparations
Alkanna cappadocica was processed to obtain a specific extract derived from its roots. This particular preparation utilized a solvent mixture consisting of dichloromethane and methanol in a 1:1 ratio. The resulting extract served as the foundation for a bioassay-guided fractionation process. Through this method, researchers were able to isolate several known and new naphthoquinones. This specific extraction technique was essential for identifying the potent cytotoxic compounds within the plant.
Parts used
Alkanna cappadocica serves as a significant subject of study in the ongoing search for novel anticancer agents. Researchers focused their investigation on the plant's root, utilizing a dichloromethane/methanol extract to isolate various naphthoquinones. This bioassay-guided fractionation successfully identified four known compounds and yielded eight unique naphthoquinones. Among these, compound 7 demonstrated remarkable cytotoxicity across several human cancer cell lines. The discovery of these mono-O-methylated alkannin derivatives provides valuable new insights into the medicinal potential of this species.